Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 4, 2010, Pages 390-396

  Rocha, W A ^a   Lunz, W ^a,b   Baldo, M P ^a   Pimentel, E B ^a   Dantas, E M ^a   Rodrigues, S L ^a   Mill, J G ^a  

^a Departamento de Ciências Fisiológicas

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

ACE inhibition; Aorta remodeling; Captopril; Cardiac hypertrophy; SHR

Indexed keywords

CAPTOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HEART BLOOD VESSEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART REMODELING; HYPERTENSION; IN VIVO STUDY; LONG TERM CARE; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURGICAL TECHNIQUE; VASCULAR REMODELING;

ANIMALIA; RATTUS;

EID: 77951896050     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500023     Document Type: Article

References (30)

1. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210.
2. Kost CK Jr, Li P, Jackson EK. Blood pressure after captopril withdrawal from spontaneously hypertensive rats. Hypertension 1995; 25: 82-87.
3. Smith PG, Poston CW, Mills E. Ontogeny of neural and nonneural contributions to arterial blood pressure in spontaneously hypertensive rats. Hypertension 1984; 6: 54-60.
4. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963; 27: 282-293.
5. Dickhout JG, Lee RM. Blood pressure and heart rate development in young spontaneously hypertensive rats. Am J Physiol 1998; 274: H794-H800.
6. Giummelly P, Lartaud-Idjouadiene I, Marque V, Niederhoffer N, Chillon JM, Capdeville-Atkinson C, et al. Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats. Hypertension 1999; 34: 207-211.
7. Bicket DP. Using ACE inhibitors appropriately. Am Fam Physician 2002; 66: 461-468.
8. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16: 603-614.
9. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-1621.
10. Paull JR, Widdop RE. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. J Hypertens 2001; 19: 1393-1402.
11. Sharma JN, Kesavarao U. Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats. Pharmacology 2002; 64: 196-200
12. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 1983; 80: 533-543.
13. Sevilla MA, Voces F, Carron R, Guerrero EI, Ardanaz N, Román LS, et al. Amlodipine decreases fibroses and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal. Life Sci 2004; 75: 881-891.
14. Guerrero EI, Ardanaz N, Sevilla MA, Arévalo MA, Montero MJ. Cardiovascular effects of nebivolol in spontaneously hypertensive rats persist after treatment withdrawal. J Hypertens 2006; 24: 151-158.
15. Cadilhac M, Giudicelli JF. Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats. Arch Int Pharmacodyn Ther 1986; 284: 114-126.
16. Chen S, Su J, Wu K, Hu W, Gardner DG, Chen D. Early captopril treatment prevents hypertrophy dependent gene expression in hearts of SHR. Am J Physiol 1998; 274: R1511-R1517.
17. Wu JN, Berecek KH. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 1993; 22: 139-146.
18. Schiffrin EL, Hayoz D. How to assess vascular remodeling in small and medium-sized muscular arteries in humans. J Hypertens 1997; 15: 571-584.
19. Wright JW, Mizutani S, Harding JW. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Heart Fail Rev 2008; 13: 367-375
20. Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ. Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res 2008; 58: 196-201.
21. Celik T, Iyisoy A, Acikel C, Yuksel C, Celik M, Yaman H, et al. The comparative effects of metoprolol and perindopril on aortic elasticity in young patients with prehypertension. Blood Press Monit 2008; 13: 169-176.
22. Egan BM, Nesbitt SD, Julius S. Prehypertension: should we be treating with pharmacologic therapy? Ther Adv Cardiovasc Dis 2008; 2: 305-314.
23. Avanza AC Jr, El Aouar LM, Mill JG. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan. Arq Bras Cardiol 2000; 74: 103-117.
24. Yajima Y, Ito S, Komatsu K, Tsukamoto K, Matsumoto K, Hirayama A. Enhanced response from the caudal pressor area in spontaneously hypertensive rats. Brain Res 2008; 1227: 89-95.
25. Veliotes DG, Woodiwiss AJ, Deftereos DA, Gray D, Osadchii O, Norton GR. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension 2005; 45: 914-920.
26. Busatto VC, Cunha V, Cicilini MA, Mill JG. Differential effects of isoproterenol on the activity of angiotensin-converting enzyme in the rat heart and aorta. Braz J Med Biol Res 1999; 32: 355-360.
27. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36: 312-318.
28. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort. BMJ 2002; 325: 815.
29. Nelson M, Reid C, Krum H, McNeil J. A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs. Am J Hypertens 2001; 14: 98-105.
30. Takata Y, Yoshizumi T, Ito Y, Ueno M, Tsukashima A, Iwase M, et al. Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives. Am Heart J 1992; 124: 1574-1580.